Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2018 ZIEKTE NETWERK PROJECTS INLOGGEN
 
 
  
Sponsoring -
--->Nieuws
[-]Het Project
--->Sponsor
--->[+]Executive Committee
--->[+]Writing Committee Strategic ...
--->[+]Scientific and Bioethics Advis...
--->Centrale Coördinatie
--->Landelijke Coördinatie
--->Fellowship Programme
--->[+]Constitution
--->[-]Members
--->Request
[-]Landen
--->[+]Oostenrijk
--->[+]België
--->[+]Czech Republic
--->[+]Denemarken
--->[+]Finland
--->[+]Frankrijk
--->[+]Duitsland
--->[-]Ireland
--->Coordination
--->HD Associations
--->Dublin
--->[+]Galway
--->[+]Italië
--->[+]Nederland
--->[+]Norwegen
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[+]Spanje
--->[+]Zweden
--->[+]Zwitserland
--->[+]Groot-Brittannië
--->[-]Outside Europe
--->[+]Seoul
--->[-]Singapore
--->Contacts
--->Documents
--->Sydney
[-]Werkgroepen
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[-]Biological Modifiers
--->Dates
--->[-]Meetings
--->Meeting 2008/04
--->Meeting 2008/09
--->Meeting 2009
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[-]Imaging
--->[-]Dates
--->[-]Meetings
--->Meeting 2007
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->Meeting 2014
--->Meeting 2016
--->[+]Juvenile HD
--->[-]Motor Phenotype
--->[-]Dates
--->[-]Meetings
--->Meeting 2005/09
--->Meeting 2006/02
--->Meeting 2008/09
--->Meeting 2009
--->[+]Neuroprotective Therapy
--->[-]Physiotherapy
--->Dates
--->[-]Meetings
--->Meeting 2008/05
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->Meeting 2014
--->Meeting 2015
--->Meeting 2016
--->Call 2017 Subgroup Guide...
--->Meeting 2018
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Young Adults
[-]Events
--->[+]EHDN 2018
--->[-]EHDN 2016
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Floor plan
--->[-]Overduin Registration
--->Register
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel booking
--->Social activities
--->Reimbursement
--->[+]Abstract Submission
--->Contacts
--->Documents
--->Feedback
--->EHDN 2014
--->[+]EHDN 2012
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[+]Communicatie
--->Vacatures
EHDN would like to thank the CHDI Foundation, Inc. for making this event possible.

Additional Sponsors:

TEVA Pharmaceuticals - Platinum Sponsorship (25.000€)

UniQure – Silver Sponsorship (10.000€)

Pfizer – Silver Sponsorship (10.000€)

BioRep SRL - Bronze Sponsorship (6.000€)

AOP Orphan Pharmaceuticals AG - Bronze Sponsorship (5.000€)

Raptorpharma - Bronze Sponsorship (5.000$)

Roche - Bronze Sponsorship (5.000€)

Shire - Bronze Sponsorship (5.000€)

We also thank the city of The Hague for supporting our Plenary Meeting and helping to finance the Saturday evening event.
  
about us | privacy statement | disclaimer | terms of use